DMRA
Damora Therapeutics, Inc. has filed 329 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (103 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G | - | 2026-05-15 | - |
| Quarterly report | 10-Q | 2026-05-12 | 2026-03-31 |
| New insider ownership | 3 | 2026-05-08 | 2026-05-01 |
| Major company event | 8-K | 2026-05-04 | 2026-04-28 |
| Annual report to shareholders | ARS | 2026-05-01 | 2025-12-31 |
| Proxy statement | DEF 14A | 2026-04-29 | 2026-04-29 |
| Proxy materials | DEFA14A | 2026-04-29 | - |
| SCHEDULE 13G/A | - | 2026-04-23 | - |
| SCHEDULE 13G/A | - | 2026-04-23 | - |
| Major company event | 8-K | 2026-04-20 | 2026-04-17 |
| Insider trade | 4 | 2026-04-01 | 2026-03-30 |
| New insider ownership | 3 | 2026-04-01 | 2026-03-30 |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| New insider ownership | 3 | 2026-03-25 | 2026-03-23 |
| New insider ownership | 3 | 2026-03-25 | 2026-03-23 |
| Major company event | 8-K | 2026-03-23 | 2026-03-20 |
| Employee stock plan | S-8 | 2026-03-20 | - |
| Annual report | 10-K | 2026-03-19 | 2025-12-31 |
| Major company event | 8-K | 2026-03-10 | 2026-03-06 |
| SCHEDULE 13G/A | - | 2026-03-06 | - |
| SCHEDULE 13G | - | 2026-02-17 | - |
| SCHEDULE 13G | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-12 | 2026-02-09 |
| Insider trade | 4 | 2026-02-12 | 2026-02-09 |
| SCHEDULE 13D/A | - | 2026-02-11 | - |
| Major company event | 8-K | 2026-02-11 | 2026-02-10 |
| Prospectus supplement | 424B5 | 2026-02-11 | - |
| Prospectus supplement | 424B5 | 2026-02-10 | - |
| S-3ASR | - | 2026-02-10 | - |
| Major company event | 8-K | 2026-02-10 | 2026-02-06 |
| Insider trade | 4 | 2026-01-26 | 2026-01-05 |
| New insider ownership | 3 | 2026-01-26 | 2026-01-05 |
| SCHEDULE 13G | - | 2026-01-12 | - |
| SCHEDULE 13G | - | 2026-01-12 | - |
| Major company event | 8-K | 2026-01-12 | 2026-01-12 |
| Insider trade | 4 | 2026-01-07 | 2026-01-05 |
| New insider ownership | 3 | 2026-01-07 | 2026-01-05 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Major company event | 8-K | 2026-01-06 | 2025-12-31 |
| Employee stock plan | S-8 | 2026-01-02 | - |
| 424B3 | - | 2025-12-31 | - |